PHusis Therapeutics, Inc. logo

PHusis Therapeutics, Inc.

PHusis Therapeutics is developing novel targeted small molecule therapeutics that bind and block the pleckstrin homology (PH)-domain of critical signaling proteins involved in driving cancer cell growth and survival in patients with limited treatment options.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.phusistherapeutics.com
Founded2009
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3210 Merryfield Row, CA 92121
San Diego
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/phusis-therapeutics-inc.” connections=”true” suffix=””]